Sector: Pharmaceuticals & Biotechnology

Large Cap

GlaxoSmithKline Share Price

GlaxoSmithKline Pharmaceuticals Ltd.

₹2,635.30

38.40(1.48%)

Invest in GLAXO with up to 2.50x margin.

Trade with MTF

23rd Feb 2026 | 3:28 PM

NSE : GLAXO

Open Free Demat Account

GlaxoSmithKline Performance

Price Movement

₹2635.30

₹2610.50

₹2668.80

↘ Today's Low↗ Today's High

1 Year Performance

₹2635.30

₹2220.30

₹3515.70

↘ 52 Week Low↗ 52 Week High

Markets Today

High₹2,668.80

Low₹2,610.50

Open at₹2,616.80

Prev Close₹2,596.90

Volumes59.25 K

Avg Price₹2,642.06

Lower Circuit₹2,077.60

Upper Circuit₹3,116.20

Historical Performance

3M High₹2,719.80

3M Low₹2,220.30

1 Yr High₹3,515.70

1 Yr Low₹2,220.30

3 Yr High₹3,515.70

3 Yr Low₹1,227.00

5 Yr High₹3,515.70

5 Yr Low₹1,227.00

GlaxoSmithKline Fundamentals

Market Cap

High in industry

44,699.50 Cr.

PE Ratio (TTM)

High in industry

43.80

Dividend Yield

High in industry

1.60

Net Profit TTM

18.8% incr over last year

1,020.99

Net Profit Growth

18.8% incr over last year

1,020.99

PEG Ratio

High in industry

2.30

ROE

42.6% incr over last year

47.67

Operating Revenue TTM

3,800.74

Operating Revenue Growth

2.6% incr over last year

Book Value

High in industry

26.20

MFI

MFI is mid-range

69.28

RSI

RSI is mid-range

59.12

EPS (TTM)

54.52

Debt to Equity

Face Value

Operating Profit Margin Qtr.

30.23

Operating Profit Qtr.

371.34

Net Profit Qtr.

295.62

Operating Revenue Qtr.

1,041.26

PB Ratio

26.20

GlaxoSmithKline Financials

*All values are in Rs. Cr

Loading chart...

Indicator	Dec 2025	Sep 2025	Jun 2025	Mar 2025	Dec 2024
Total Revenue	1,022.59	973.63	804.83	966.08	946.36
Operating Expense	655.01	638.95	554.08	635.34	656.18
Operating Profit	367.58	334.68	250.75	330.74	290.18
Depreciation	20.32	17.43	15.52	14.72	18.80
Interest	1.19	0.51	0.42	0.58	0.09
Tax	100.71	95.65	73.87	94.76	77.77
Net Profit	277.18	255	204.70	260.14	228.58

GlaxoSmithKline Technicals

GlaxoSmithKline Pharmaceuticals Ltd. EMA & SMA

₹2635.30

38.40 (1.48%)

↗ Bullish Moving Average

↘ Bearish Moving Average

Day EMA5 ₹2592.4

Day EMA10 ₹2576.1

Day EMA12 ₹2566.3

Day EMA20 ₹2532.8

Day EMA26 ₹2517.3

Day EMA50 ₹2506.5

Day EMA100 ₹2560.9

Day EMA200 ₹2625.8

GlaxoSmithKline Support and Resistance

Resistance

First Resistance₹2618.83

Second Resistance₹2640.77

Third Resistance₹2671.13

Support

First Support₹2566.53

Second Support₹2536.17

Third Support₹2514.23

Technical Indicators

Day RSI59.12

Day MFI69.28

Day ADX26.99

Day Commodity Channel Index54.20

William-35.16

Day MACD49.02

Day MACD Signal Line40.47

Day ATR74.06

Day ROC125-6.60

Day ROC219.10

GlaxoSmithKline Shareholding Pattern

Held By	Sep 2024	Dec 2024	Mar 2025	Jun 2025	Sep 2025	Dec 2025
Promoter	75	75	75	75	75	75
FII	4.4	4.5	4.5	4.9	5	4.6
DII	7.3	7.3	7.8	7.7	8	7.7
Public	13.3	13.2	12.7	12.4	12	12.7

GlaxoSmithKline Delivery And Volume

Period	Combined Delivery Volume	NSE+BSE Traded Volume Avg	Daily Avg Delivery Volume %
Day	24.85 K	40.42 K	61.47%
Week	33.63 K	54.93 K	61.21%
1 Month	43.85 K	84.43 K	51.94%
6 Month	53.69 K	87.5 K	61.36%

GlaxoSmithKline SWOT Analysis

Strengths25

Weakness3

Opportunity1

Threats2

Positive Breakout First Resistance ( LTP > R1)

Companies with no Debt

Benjamin Graham Value Screen

Stocks in Buy Zone with High Momentum Score Last Month

Mid-range Performer (DVM)

Relative Outperformance versus Industry over 1 Month

Rising Net Cash Flow and Cash from Operating activity

Companies with high TTM EPS Growth

Annual Profit Growth higher than Sector Profit Growth

PEG lower than Industry PEG

Dividend yield greater than sector dividend yield

Relative Outperformance versus Industry over 1 Month

Effectively using its capital to generate profit - RoCE improving in last 2 years

Growth in Net Profit with increasing Profit Margin (QoQ)

Growth in Quarterly Net Profit with increasing Profit Margin (YoY)

Increasing Revenue every quarter for the past 2 quarters

Increasing profits every quarter for the past 2 quarters

Strong cash generating ability from core business - Improving Cash Flow from operation for last 2 years

Company able to generate Net Cash - Improving Net Cash Flow for last 2 years

Book Value per share Improving for last 2 years

Companies with Zero Promoter Pledge

RSI indicating price strength

Top Gainers

Volume Shockers

Stocks Outperforming their Industry Price Change in the Quarter

GlaxoSmithKline Corporate Action

Ex-Date	Dividend Amount	Dividend Type	Record Date	Instrument Type
30 May, 2025	42	FINAL	30 May, 2025	Equity Share
07 Nov, 2024	12	INTERIM	07 Nov, 2024	Equity Share
31 May, 2024	32	FINAL	31 May, 2024	Equity Share
30 Jun, 2023	32	FINAL	30 Jun, 2023	Equity Share
07 Jul, 2022	60	SPECIAL	08 Jul, 2022	Equity Share
07 Jul, 2022	30	FINAL	08 Jul, 2022	Equity Share
19 Jul, 2021	30	FINAL	20 Jul, 2021	Equity Share
17 Jul, 2020	20	SPECIAL	20 Jul, 2020	Equity Share
17 Jul, 2020	20	FINAL	20 Jul, 2020	Equity Share
11 Jul, 2019	20	FINAL		Equity Share

GlaxoSmithKline Stock Comparison

Financials	Anthem Biosciences Ltd.	Emcure Pharmaceuticals Ltd.	Mankind Pharma Ltd.	Piramal Pharma Ltd.	Gland Pharma Ltd.	Laurus Labs Ltd.
Price (₹)	₹696.90	₹1,431.80	₹2,045	₹162	₹1,803	₹1,014.60
% Change	2.20%	-0.42%	1.02%	0.92%	-1.03%	-0.43%
Revenue TTM (₹ Cr)	₹1,996.59	₹8,850.08	₹13,914.08	₹8,871.37	₹6,112.77	₹6,721.63
Net Profit TTM (₹ Cr)	₹484.66	₹869.92	₹1,779.35	₹-163.61	₹847.18	₹843.32
PE TTM	80.70	31.30	47.50	-131.70	35.10	65.10
1 Year Return	22.17	44.17	-12.08	-22.44	18.09	95.04
ROCE	26.88	20.80	13.27	6.40	11.43	11.82

Similar Stocks

ALKEM

Alkem Laboratories Ltd.

₹ 5487.00

+1.76%

BIOCON

Biocon Ltd.

₹ 388.00

+1.05%

DIVISLAB

Divi's Laboratories Ltd.

₹ 6258.50

-0.52%

AJANTPHARM

Ajanta Pharma Ltd.

₹ 2975.00

+1.21%

ZYDUSLIFE

Zydus Lifesciences Ltd.

₹ 905.30

GLENMARK

Glenmark Pharmaceuticals Ltd.

₹ 2033.00

-0.50%

WOCKPHARMA

Wockhardt Ltd.

₹ 1370.00

-0.84%

AUROPHARMA

Aurobindo Pharma Ltd.

₹ 1148.70

-0.87%

SUNPHARMA

Sun Pharmaceutical Industries Ltd.

₹ 1732.00

+0.44%

IPCALAB

Ipca Laboratories Ltd.

₹ 1469.70

+1.37%

JBCHEPHARM

J B Chemicals & Pharmaceuticals Ltd.

₹ 2051.00

+2.53%

ASTRAZEN

AstraZeneca Pharma India Ltd.

₹ 8807.00

-0.93%

PFIZER

Pfizer Ltd.

₹ 5066.60

+2.74%

ABBOTINDIA

Abbott India Ltd.

₹ 26425.00

+0.49%

TORNTPHARM

Torrent Pharmaceuticals Ltd.

₹ 4318.50

+1.81%

LUPIN

Lupin Ltd.

₹ 2241.00

+0.97%

DRREDDY

Dr. Reddy's Laboratories Ltd.

₹ 1305.10

+1.93%

CIPLA

Cipla Ltd.

₹ 1327.00

-1.05%

FAQ's on GLAXO

What is the current share price of GlaxoSmithKline Pharmaceuticals Ltd.?

As of 6 June 2025 at 10:01 AM, the share price for GlaxoSmithKline Pharmaceuticals Ltd. is ₹ 2635.3 on the NSE and ₹ 2633.35 on the BSE. (Note: Prices are dynamic and update frequently during market hours).

What is the Market Capitalization of GlaxoSmithKline Pharmaceuticals Ltd.?

Market capitalization (market cap) represents the total market value of a company's outstanding shares based on its current share price. As of 6 June 2025, the market cap for GlaxoSmithKline Pharmaceuticals Ltd. is approximately ₹ 44699.5 Cr.

What are the PE and PB ratios for GlaxoSmithKline Pharmaceuticals Ltd.?

Based on recent data, the Price-to-Earnings (PE) ratio for GlaxoSmithKline Pharmaceuticals Ltd. is 43.8, and the Price-to-Book (PB) ratio is 26.2.

What is the 52-Week High and Low for GlaxoSmithKline Pharmaceuticals Ltd.?

Over the past 52 weeks, the highest price reached by GlaxoSmithKline Pharmaceuticals Ltd. shares was ₹ 3515.7, and the lowest price was ₹ 2220.3.

What is the current dividend yield for GlaxoSmithKline Pharmaceuticals Ltd.?

As of 6 June 2025, the dividend yield for GlaxoSmithKline Pharmaceuticals Ltd. is 1.6%. The dividend yield is calculated based on the company's annual dividend payouts relative to its current share price.

Who are the major shareholders of GlaxoSmithKline Pharmaceuticals Ltd.?

Significant shareholdings in GlaxoSmithKline Pharmaceuticals Ltd. typically include entities such as:

Promoter
Public
Mutual Funds
FII
Other Institutions

(Note: Shareholding patterns can change; this represents major holders based on recent filings).

Who are the peers of GlaxoSmithKline Pharmaceuticals Ltd. in the Pharmaceuticals & Biotechnology sector?

In the Pharmaceuticals & Biotechnology sector, GlaxoSmithKline Pharmaceuticals Ltd. is often compared with other major players such as Accretion Nutraveda, Rekvina Laboratories, Vivimed Labs, Corona Remedies, Sudeep Pharma and Curis Lifesciences for analysis and benchmarking.

What is the latest dividend information for GlaxoSmithKline Pharmaceuticals Ltd.?

GlaxoSmithKline Pharmaceuticals Ltd. last declared a FINAL dividend of ₹ 42 per share for the financial period ending 2025. The record date was set as 2025-05-30, and the payment was/is scheduled around 2025-05-30. For the most current dividend announcements, refer to official company filings.

Invest Anytime, Anywhere

By signing up I certify terms, conditions & privacy policy